This page was printed from the South & West Devon Formulary and Referral site at
Please ensure you are using the current version of this document
The formulary is managed by the South & West Devon Formulary Interface Group (FIG):
See below for the minutes from the South and West Devon Formulary Interface Group meetings:
To provide a forum for the Northern, Eastern and Western Devon Clinical Commissioning Group (NEW Devon CCG) and the South Devon and Torbay Clinical Commissioning Group (SD&T CCG) to work with the provider trusts it commissions to incorporate national and local treatment choices and guidance into a Joint Formulary.
The South and West Devon Formulary Interface Group (FIG) will:
The South and West Formulary Interface Group is a multi-stakeholder group whose membership is intended to reflect the needs of the localities and organisations involved. The core membership comprises:
The FIG Chair will be selected from the core membership by the group. When absence is anticipated the Chair will nominate an existing group member to deputise for that meeting. Otherwise the committee will nominate a Chair from those present on the day.
The membership is supplemented by a number of co-opted members appointed because of their level of knowledge and experience.
Clinical specialists and other stakeholders can be invited to attend relevant meetings.
Meetings will be conducted regularly at a frequency agreed by the group.
Meetings of the Group will be formal and appropriate agenda and minutes produced.
Draft minutes will be sent initially to the Chair and subsequently to FIG members for comment. Meeting papers will be disseminated to FIG members prior to each meeting.
Administrative support will be provided by the Clinical Effectiveness Team, NEW Devon CCG.
Meetings may be attended in person or via teleconferencing where services exist.
For the Group to be quorate there will be at least two medical practitioners (of whom at least one is a General Practitioner) and two pharmacist representatives (of whom at least one must be from the Clinical Effectiveness or Medicines Optimisation Teams in NEW Devon CCG, or Medicines Optimisation Team in SD&T CCG).
Decisions are taken via a consensus approach.
In addition to the face to face meetings with formal agendas and minutes e-FIG meetings will be held, as per the agreed process, as required for appropriate items. The outcomes of e‑FIG meetings will be reported and recorded in the minutes of the subsequent face to face meeting.
The South and West Devon Formulary Interface Group will provide progress reports for the Clinical Policy Committee. This group reports to the Clinical Commissioning Group Governing Boards.
Minutes of the South and West Devon Formulary Interface Group will be made available on the Joint Formulary website.
The Terms of Reference will be reviewed annually and available on the Joint Formulary website.
All members of the committee and attendees will be expected to complete and submit a declaration of interest prior to the meeting. The Chair will ask that declarations of interest are made known to the committee members to indicate any issues where there is a personal competing interest whether financial, academic, or research. These are recorded in the minutes of the appropriate meeting and in the Annual Report.
Declaration of interests will be expected for items discussed via e-FIG meetings. Any interests will be declared in the e-FIG response and formally recorded at the next FIG meeting.